KCG
ASTX

Knight Capital Group’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

Knight Capital Group’s Portfolio ASTX Stock Details ASTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$305K Buy
+74,499
New +$401K 0.01% 2218

Other funds holding ASTX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Knight Capital Group's ASTX Position: Q2 2013 in Review

Knight Capital Group opened a new position in ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q2 2013: 74,499 shares worth $305K. The stake represents 0.01% of the portfolio and ranks #2218 among its holdings.

120 funds tracked by Wall St. Rank hold ASTX as of Q2 2013.

  • Knight Capital Group held 74,499 shares of ASTEX PHARMACEUTICALS, INC COM worth $305K as of Q2 2013.
  • ASTEX PHARMACEUTICALS, INC COM was a new Knight Capital Group position in Q2 2013.
  • ASTEX PHARMACEUTICALS, INC COM made up 0.01% of Knight Capital Group's portfolio in Q2 2013, its #2218 holding.
  • 120 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.